The Next Generation Biotech Media
On December 23rd, Israel-based Compugen, a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, achieved a preclinical milestone in developing bispecific and multi-specific antibody products with AstraZeneca. …
Read More
On November 17th, BioMarin Pharmaceuticals announced that it is collaborating with Toronto-based Deep Genomics to utilize the latter’s proprietary artificial-intelligence-based drug discovery platform to unravel new drugs for rare diseases. …
Read More
By Rajaneesh K. Gopinath, Ph.D. Since the outbreak of the pandemic, the California-based company has formed several collaborative partnerships to strengthen its pursuit of identifying antibodies against the SARS-CoV-2 virus. …
Read More
0316-0322 By Ching-Hsu Yang, Donna Lee 1. Eisai To Launch “NouKNOWTM” in Japan for Regular Self-assessment of Brain Health On March 23, 2020, Eisai Co., Ltd. revealed the introduction of …
Read More
The non availability of patient tissue samples or the challenges that exists in obtaining them impedes data inference from clinical trials. In contrast, NGS analysis of patient blood samples provide …
Read More